Luo Wang
Impact in
- Cancer Research top 10%
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- DNA Repair Mechanisms
- Ubiquitin and proteasome pathways
Papers in
-
- RNA modifications and cancer 11
- Epigenetics and DNA Methylation 9
- Cancer-related gene regulation 5
- Ubiquitin and proteasome pathways 4
- Protein Degradation and Inhibitors 4
- Oncology 9
- Co-authors
- Li Mao (7 shared papers)Waun Ki Hong (7 shared papers)Qingyi Wei (10 shared papers)Margaret R. Spitz (4 shared papers)Yoon Soo Chang (4 shared papers)Ho‐Young Lee (4 shared papers)Jean‐Charles Soria (3 shared papers)Hongbing Shen (1 shared paper)
- Journals
- Clinical Cancer Research (3 papers)Cancer Research (3 papers)ChemBioChem (2 papers)International Journal of Oncology (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Luo Wang
56 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 152
- Molecular Biology 736
- Oncology 157
- Aging 11
- Immunology 123
Countries citing papers authored by Luo Wang
This map shows the geographic impact of Luo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luo Wang more than expected).
Fields of papers citing papers by Luo Wang
This network shows the impact of papers produced by Luo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luo Wang. The network helps show where Luo Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Luo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. | 2002 | 148 |
| 2 | Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. | 2001 | 137 |
| 3 | Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer. | 2002 | 117 |
| 4 | 2004 | 73 | |
| 5 | 2006 | 58 | |
| 6 | 2004 | 57 | |
| 7 | 2003 | 54 | |
| 8 | 2006 | 54 | |
| 9 | 2008 | 47 | |
| 10 | 2004 | 35 | |
| 11 | 2022 | 29 | |
| 12 | 2018 | 26 | |
| 13 | 2023 | 25 | |
| 14 | 2023 | 24 | |
| 15 | TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer. | 2001 | 24 |
| 16 | 2007 | 23 | |
| 17 | 2022 | 20 | |
| 18 | 2014 | 19 | |
| 19 | 2010 | 19 | |
| 20 | 2022 | 18 |
About Luo Wang
Luo Wang is a scholar working on Molecular Biology, Oncology, Immunology, Aquatic Science and Pulmonary and Respiratory Medicine, having authored 60 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Epigenetics and DNA Methylation (9 papers), Cancer-related gene regulation (5 papers), Ubiquitin and proteasome pathways (4 papers), Echinoderm biology and ecology (4 papers), Protein Degradation and Inhibitors (4 papers), Marine Bivalve and Aquaculture Studies (4 papers) and Marine Biology and Environmental Chemistry (3 papers). The work is most often cited by research in Cancer Research (152 citations), Molecular Biology (736 citations), Oncology (157 citations), Aging (11 citations) and Immunology (123 citations). Luo Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Li Mao, Waun Ki Hong, Qingyi Wei, Margaret R. Spitz, Yoon Soo Chang, Ho‐Young Lee, Jean‐Charles Soria, Hongbing Shen, Fadlo R. Khuri and Li‐E Wang. Their work appears in journals such as Clinical Cancer Research, Cancer Research, ChemBioChem, International Journal of Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.